MEETING DETAILS

`
Main Meeting:
Atendees:
Location:
Website:
AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

Sat, April 17th - Thurs, Apr 22nd

Kimberly Phelps-Weber, Rajvi Shah
Virtual Meeting
https://www.aan.com/msa/public/events/index/34

Confidential; for planning purposes only; do not distribute

Saturday, April 17th
Emerging Trends: State-of-the-Art for Experts (Registration required)

TIME
1:00 - 1:20

1:00 - 2:00

2:00-3:00

2:00-3:00
4:00-5:00
rday, April 17th
ng Trends: State-of-the-Art for Experts (Registration required)

SESSION NAME
Digital Assessments transforming Neurology

Industry Therapeutic Update from EMD Serono, Inc.: Current

considerations in MS patient management in the real world

Industry Therapeutic Update from Novartis Pharmaceuticals

Corporation: KESIMPTA® (ofatumumab) for Relapsing MS:
C10 - Multiple Sclerosis Overview
Lilyana M. Amezcua, MD, FAAN

S2 Advaces in MS Imaging
C15 Update in Movement Disorders
Confidential; for planning purposes only
Kimberly Phelps-Weber

SPEAKERS/COMPANY PRIORITY
Allen L. Gee, MD, PhD, FAAN
KPW

Deborah Hall, MD
Sunday, April 18

TIME
9:00- 10:00

9:00-10:00

1:00 - 2:00

2:00- 3:00

3:00- 4:30

4:00 5::00

6:00-7:00

7:00 - 8:00
ay, April 18

SESSION NAME
Industry Therapeutic Update from Biogen: Advancing Neurology
Practice: Adapting to Today’s World

Industry Therapeutic Update from Sunovion Pharmaceuticals Inc. Navigating the Treatment Options for
"OFF" Episodes in Parkinson’s Disease: The Role of On-Demand Treatments

Industry Therapeutic Update from BMS: ZEPOSIA® (Ozanimod): A Once-Daily Oral Option for Patients
with Relapsing Forms of MS

Industry Therapeutic Update from Sanofi Genzyme: Unmasking

Secondary Progressive MS: Revealing the Faces and Facets of
Disease Progression

S8 - Neuromodulation in Movement Disorders

Emerging Science Session

S11 - MS Immunology and Basic Science

C35 Update in movement Disorders 2

Industry Therapeutic Update from Sarepta Therapeutics: The
Potential of Gene Transfer Therapy Development for Duchenne
Muscular Dystrophy
Confidential; for planning purposes only

SPEAKERS/COMPANY PRIORITY
KPW

RS

KPW

Supported by Sarepta RS
Monday, April 19

TIME
8:00- 9:00
8:00 - 9:00

9:00-10:00

1:00 - 2:00

2:00- 3:00

4:00-5:00
6:00- 7:00
day, April 19

SESSION NAME
C39 - Multiple Sclerosis Therapy: Disease-modifying Treatment
C41 Updates in Movement Disorders Update†on Clinical Trials- in PD and HD

Industry Therapeutic Update from Sanofi Genzyme: Biomarkers,

Genetics, and Clinical Endpoints - The Road to Disease
Modification in Parkinson’s Disease

Industry Therapeutic Update from Biogen: Emerging Real-World

Evidence: Nusinersen in Adults With SMA
Industry Therapeutic Update from Biogen: The Early Diagnosis of
Alzheimer’s Disease: Addressing the Clinical Challenge
C44 - Clinical Approach to Muscle Disease
S-14 Behavioral and Cognitive Neurology
IS2 - Invited Science: Movement Disorders
C55 Autoimmune Neurology
Confidential; for planning purposes only

SPEAKERS/COMPANY PRIORITY
Jacqueline Bernard,MD RS
Tanya Simuni, MD, FAAN KPW

RS

KPW

RS

Margherita Milone, MD, FAAN KPW

RS
Irene Malaty, MD, FAAN | Andrew D. Siderowf, MD KPW
Stacey Clardy, MD, PhD, FAAN RS
Tuesday, April 20

TIME
2:00- 3:00

6:00- 7:00

7:00-8:00
day, April 20

SESSION NAME
C64 - Genetic Therapies for Neurological Diseases: Today and
Tomorrow

N4 - Neuroscience in the Clinic: CAR-T Cell Therapy: Neurologic

Applications and Neurotoxicity

Industry Therapeutic Update from nQ Medical, Inc.: Digital

Cognitive Phenotyping in Neurodegenerative Disease: Modern
Metrics for Clinical Science and Practice
Confidential; for planning purposes only

SPEAKERS/COMPANY PRIORITY
Robert C. Griggs, MD, FAAN RS

Holly E. Hinson, MD, MCR, FAAN | Antonio M. P. Omuro, MD KPW

KPW
Wednesday, April 21

TIME
4:00-5:00
nesday, April 21

SESSION NAME
S32 - Therapeutics of Genetic Neuromuscular Diseases
Confidential; for planning purposes only

SPEAKERS/COMPANY PRIORITY
Irene Malaty, MD, FAAN | Andrew D. Siderowf, MD KPW
Poster Title

043 - Burden of Illness Among US Medicare Beneficiaries with Late-Onset Huntington’s Disease

045 - Detecting Disease Onset in Huntington’s Disease with a Simple Balance Assessment
046 - Clinical Characteristics of Late-Onset Huntington’s Disease in North Americans from the Enroll-HD
Study
048 - Atypical gait in a patient with Huntington’s disease (HD): Functional movement disorders in the
spectrum of motor phenotypes in HD
049 - Understanding Deficits in the Genetics, Recognition, and Management of Huntington Disease Among
Neurologists: Results from a CME-Certified Survey

082 - Levodopa Unresponsive Freezing of Gait: Defining the Gait and Non-motor Phenotype
087 - Survival Based on Genetic and Clinical Features in Parkinson’s Disease

089 - Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk

120 - A Retrospective Study Evaluating the Use of Anti-Parkinsonian Medications in Patients with Advanced
Parkinson’s Disease Who Are Treated with Levodopa-Carbidopa Intestinal Gel and Deep Brain Stimulation:
The PD-DUAL Study
146 - Evolving inclusion criteria in early manifest Huntington’s disease (HD) to address striatal atrophy:
Lessons from HD-GeneTRX-1, the first gene therapy trial

177 - Unmet needs and treatment patterns of advanced Parkinson’s Disease patients in the United States
003 - Anti-Adeno-Associated virus (AAV) neutralizing antibody (Nab) titers in Duchenne muscular dystrophy
(DMD)

005 - Prognostic value of miR-206 in detecting evolution of Limb Girdle D2 due to TPNO3 gene mutation

044 - A phase I/II open-label gene replacement clinical study for late onset Pompe disease
Author(s) Class

Jamie Ta Movement Disorders Posters

Jody Corey-Bloom, MD, PhD, FAAN Movement Disorders Posters

Xiaoye Ma Movement Disorders Posters

Humberto Leal Bailey, MD Movement Disorders Posters

Thomas Finnegan, Jr., PhD Movement Disorders Posters

Tuhin Virmani, MD, PhD, FAAN Movement Disorders Posters

Sushma Kola, MD Movement Disorders Posters

Yingnan Han Movement Disorders Posters

Jason Lamar Aldred, MD, FAAN Movement Disorders Posters

Erin Furr-Stimming, MD Movement Disorders Posters

Irene Malaty, MD, FAAN Movement Disorders Posters

Sumit Verma, MD EMG Posters

Valentina Pegoraro EMG Posters

Tahseen Mozaffar, MD, FAAN Child Neurology Posters

MSL

RS

KPW

RS

KPW

RS